Automate Your Wheel Strategy on SNN
With Tiblio's Option Bot, you can configure your own wheel strategy including SNN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SNN
- Rev/Share 6.6514
- Book/Share 6.0274
- PB 2.4919
- Debt/Equity 0.6308
- CurrentRatio 2.8877
- ROIC 0.0612
- MktCap 13143175900.0
- FreeCF/Share 0.6938
- PFCF 21.6884
- PE 31.8447
- Debt/Assets 0.3207
- DivYield 0.025
- ROE 0.0787
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | SNN | HSBC Securities | Buy | Hold | -- | -- | April 25, 2025 |
| Downgrade | SNN | UBS | Buy | Neutral | -- | -- | March 12, 2025 |
News
SNN or ESLOY: Which Is the Better Value Stock Right Now?
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks is more attractive to value investors?
Read More
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
Published: July 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle.
Read More
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair.
Read More
SNN vs. GEHC: Which Stock Is the Better Value Option?
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors?
Read More
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures
Published: June 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. It is the only system to now offer trauma surgeons the choice of side-specific (right and left) nails for anatomic screw trajectories, which help to optimize fragment fixation and minimize soft tissue irritation with headless and low-profile screw options.1, 2 The TRIGEN MAX Tibia Nailing System aims to streamline operative procedures and provide efficiency through …
Read More
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
Published: June 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee.
Read More
Smith+Nephew Stock May Gain From Strategic Deal With Standard Health
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive
SNN teams with Standard Health to launch the United Kingdom's first orthopedic ASC, aiming to boost surgical efficiency and drive growth.
Read More
New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
Published: June 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1
Read More
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
Published: May 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA).
Read More
Smith & Nephew shares jump 7% on better-than-expected quarterly growth
Published: April 30, 2025 by: Proactive Investors
Sentiment: Positive
Smith & Nephew PLC (LSE:SN) rose as much as 7% in afternoon trading on Wednesday after the medical technology group reported stronger-than-expected revenue growth in the first quarter of 2025. The London-listed company posted underlying revenue growth of 3.1% in the three months to March, ahead market consensus of 1.9%.
Read More
Smith & Nephew jumps as hip and knee replacements in demand
Published: April 30, 2025 by: Proactive Investors
Sentiment: Positive
Smith & Nephew PLC (LSE:SN) shares rose over 5% to top the early FTSE 100 leaderboard on Wednesday after the knee and hip replacer maintained its full-year 2025 guidance after seeing growth of 3.1% in underlying revenue for the first quarter. The performance was supported by recent product launches and continued operational improvements across its business lines, with total reported revenue up 1.6% to $1.4 billion after a negative foreign exchange, ongoing headwinds from China and one fewer trading day compared to the prior year.
Read More
New Strong Buy Stocks for April 29th
Published: April 29, 2025 by: Zacks Investment Research
Sentiment: Positive
MATX, SNN, ALEX, PCB and LTH have been added to the Zacks Rank #1 (Strong Buy) List on April 29, 2025.
Read More
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
Published: March 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:
Read More
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
Published: March 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:
Read More
New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
Published: March 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) highlights the exceptional performance of Smith+Nephew's proprietary OXINIUM on highly cross-linked polyethylene. The data indicates that this combination has the highest survivorship rate (94.1%) among all bearing combinations over a 20-year period for total hip arthroplasty (THA).1
Read More
Smith & Nephew sees turnaround plan kicking in as profit grows
Published: February 25, 2025 by: Proactive Investors
Sentiment: Positive
Smith & Nephew PLC has said 2025 should show its transformation plan kicking in despite ongoing woes in China after improving trading over the last year. Revenue climbed 4.7% to US$5.8 billion in the year to December 31, the medical equipment maker said Tuesday, aiding an 8.2% increase in trading profit to US$1.1 billion.
Read More
UK's Smith+Nephew beats annual profit expectations
Published: February 25, 2025 by: Reuters
Sentiment: Positive
Smith+Nephew beat analysts' expectations for annual sales and profit on Tuesday, as a recovery in its U.S. knee and hip implant business, along with cost cuts, helped the medical products maker offset the impact of weak demand from China.
Read More
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
Published: February 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
First in market to o ffe r A djustable T ensioning T echnology * for i nsertional A chilles r econstruction and l ateral a nkle i nstability r epair
Read More
About Smith & Nephew plc (SNN)
- IPO Date 1999-11-16
- Website https://www.smith-nephew.com
- Industry Medical - Devices
- CEO Deepak S. Nath
- Employees 17349